MedTrace Logo

Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects

NCT01736735 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2014-03-05

No results posted yet for this study

Summary

This is a placebo-controlled study to determine the effect of CLP in heart failure subjects with fluid overload.

Conditions

Interventions

DRUG

CLP

DRUG

placebo

Sponsors & Collaborators

  • Sorbent Therapeutics

    lead INDUSTRY

Principal Investigators

  • Howard Dittrich, MD · Sorbent Therapeutics, Study Sponsor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States
  • Argentina
  • Israel

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01736735 on ClinicalTrials.gov